All filters
Videos
Implementing LA-ARVs in Europe: Which Patient? Which Formulation?
Presented at:
European Meeting on HIV & Hepatitis 2022
Videos
HIV Care and War in Ukraine
Presented at:
European Meeting on HIV & Hepatitis 2022
Videos
The Top 10 Important Observations Last Year
Presented at:
European Meeting on HIV & Hepatitis 2022
Videos
Country Experiences: Southern Europe / Italy
Presented at:
European Meeting on HIV & Hepatitis 2022
Videos
Country Experiences: Northern Europe / Sweden
Presented at:
European Meeting on HIV & Hepatitis 2022
Videos
Country Experiences: Eastern Europe / Czech Republic
Presented at:
European Meeting on HIV & Hepatitis 2022
Videos
Country Experiences: Western Europe / France
Presented at:
European Meeting on HIV & Hepatitis 2022
Videos
Impact of Covid Pandemic on HIV Epidemiology and Cascade of Care in Europe
Presented at:
European Meeting on HIV & Hepatitis 2022
Videos
Special Lecture: Current Outbreaks of Concern
Presented at:
European Meeting on HIV & Hepatitis 2022
Videos
Early Clinical Phase - Antiviral Drugs
Presented at:
European Meeting on HIV & Hepatitis 2022
Videos
Early Clinical Phase - Monoclonal Antibodies
Presented at:
European Meeting on HIV & Hepatitis 2022
Videos
Impact of Variants on Clinical Presentation and Outcome in Severe COVID Disease
Presented at:
European Meeting on HIV & Hepatitis 2022
Videos
Dimitrios Paraskevis | European Meeting on HIV & Hepatitis 2022, Day 1
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Seroprevalence of SARS-CoV-2 infection and evolution of humoral immune response in PLWHIV in the Ile-de-France area
B. Abdi Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
HIV-1 Integrase Resistance Associated Mutations and the Use of Dolutegravir in Sub- Saharan Africa: A Systematic Review and Meta-Analysis
E. Semengue Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
HIV transmission clusters in Europe: A perspective view of Late presenters and Non-Late presenters
Mafalda N.S. Miranda Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Characterization of SARS-CoV-2 epidemic and transmission dynamics in children over the four COVID-19 waves
R. ScutariĀ  Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Circulation of sars-cov-2 variants in central Italy: spike variability characterization by deep-sequencing
M. Bellocchi Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
SARS-CoV-2 mutations and variants may muddle the sensitivity of COVID-19 diagnostic assays
M. Alkhatib Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Impact of SARS-CoV-2 omicron and delta sub-lineage AY.4.2 variant on neutralization by sera of patients treated with different licensed monoclonal antibodies
L. Fiaschi Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Levels and durability of humoral and T-specific responses after the booster dose of mRNA BNT162b2 vaccine in residents of a Long Term Care Facility
A. Bergna Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Transmitted drug resistance to integrase based first-line treatment in Europe, 2018-2021
F. Garcia Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
HIV-1 Transmitted drug resistance and transmission clusters in newly diagnosed patients in Portugal between 2014 and 2019
M. Pingarilho Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Reaching the 95-95-95 targets will not eliminate HIV transmission in 2030 among individuals born in sub-Saharan Africa residing in the Netherlands
S. Mukherjee Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022